Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannes Lindahl

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|March 11, 2021
Interleukin-22 Influences the Th1/Th17 AxisHannes Lindahl, Tomas Olsson
Cardiovascular Research|December 4, 2025
Graft vs. atheroma in a battle of host dominionAnton Gisterå, Hannes Lindahl
Frontiers in Immunology|February 7, 2022
Neuroinflammation Associated With Inborn Errors of ImmunityHannes Lindahl, Yenan T Bryceson
Open Forum Infectious Diseases|November 29, 2023
Product Choice Affects Risk of False-Positive Hepatitis B Virus Serology During Immunoglobulin Replacement TherapyHannes Lindahl, Anna-Carin Norlin, Peter Bergman
Clinical Immunology Communications|April 15, 2024
COVID-19 in a patient with Good's syndrome and in 13 patients with common variable immunodeficiencyHannes Lindahl, C I Edvard Smith, Peter Bergman
Journal of Neurochemistry|June 17, 2025
Extensive Clinical Flow Cytometric Lymphocyte Phenotyping in Myasthenia Gravis: A Single-Center StudyHannes Lindahl, Malin Petersson, Sara Lind Enoksson, et al.
Heliyon|February 26, 2024
The clinical spectrum of ataxia telangiectasia in a cohort in SwedenHannes Lindahl, Eva Svensson, Annika Danielsson, et al.
European Journal of Immunology|March 12, 2026
Viral Immunity in Immunoglobulin Products: Global Immunity Debt and Autoimmunity in the Postpandemic EraHannes Lindahl, Katy Shaw-Saliba, H Benjamin Larman, et al.
Bone Marrow Transplantation|February 25, 2022
Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemiaHannes Lindahl, Sofie Vonlanthen, Davide Valentini, et al.
Ejhaem|December 5, 2022
Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage-specific chimerism analysisHannes Lindahl, Davide Valentini, Sofie Vonlanthen, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|March 11, 2021
Interleukin-22 Influences the Th1/Th17 AxisHannes Lindahl, Tomas Olsson
Cardiovascular Research|December 4, 2025
Graft vs. atheroma in a battle of host dominionAnton Gisterå, Hannes Lindahl
Frontiers in Immunology|February 7, 2022
Neuroinflammation Associated With Inborn Errors of ImmunityHannes Lindahl, Yenan T Bryceson
Open Forum Infectious Diseases|November 29, 2023
Product Choice Affects Risk of False-Positive Hepatitis B Virus Serology During Immunoglobulin Replacement TherapyHannes Lindahl, Anna-Carin Norlin, Peter Bergman
Clinical Immunology Communications|April 15, 2024
COVID-19 in a patient with Good's syndrome and in 13 patients with common variable immunodeficiencyHannes Lindahl, C I Edvard Smith, Peter Bergman
Journal of Neurochemistry|June 17, 2025
Extensive Clinical Flow Cytometric Lymphocyte Phenotyping in Myasthenia Gravis: A Single-Center StudyHannes Lindahl, Malin Petersson, Sara Lind Enoksson, et al.
Heliyon|February 26, 2024
The clinical spectrum of ataxia telangiectasia in a cohort in SwedenHannes Lindahl, Eva Svensson, Annika Danielsson, et al.
European Journal of Immunology|March 12, 2026
Viral Immunity in Immunoglobulin Products: Global Immunity Debt and Autoimmunity in the Postpandemic EraHannes Lindahl, Katy Shaw-Saliba, H Benjamin Larman, et al.
Bone Marrow Transplantation|February 25, 2022
Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemiaHannes Lindahl, Sofie Vonlanthen, Davide Valentini, et al.
Ejhaem|December 5, 2022
Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage-specific chimerism analysisHannes Lindahl, Davide Valentini, Sofie Vonlanthen, et al.
Pageof 2